摘要
目的分析胺碘酮治疗急性心肌梗死后室性心律失常临床效果效果。方法共纳入2015年12月-2017年12月从我院药剂科领取胺碘酮的急性心肌梗死后室性心律失常患者共86例作为观察组,同期纳入从我院药剂科领取利多卡因的急性心肌梗死后室性心律失常患者85例作为对照组,比较两组临床效果。结果对照组总有效63例(72.94%)明显低于观察组总有效79例(91.86%),差异显著(P<0.05)。对照组不良反应发生共23例(27.06%)明显高于观察组不良反应发生5例(5.81%),具有统计学意义(P<0.05)。结论针对急性心肌梗死后室性心律失常患者采用胺碘酮静脉给药联合口服给药,可提高临床疗效,降低不良反应,值得临床应用与推广。
Objective To analyze the clinical effect of amiodarone on ventricular arrhythmia after acute myocardial infarction. Methods From December 2015 to December 2017, a total of 86 patients with ventricular arrhythmias after acute myocardial infarction who received amiodarone from our pharmacy department were included as the observation group. The same period was included in the pharmacy department of our hospital. 85 patients with ventricular arrhythmias after acute myocardial infarction receiving lidocaine were treated as control subjects, and the clinical effects were compared between the two groups. Results The total effective 63 patients（72.94%） in the control group was significantly lower than the total effective 79 patients（91.86%） in the observation group. The difference was significant（P〈0.05）. A total of 23 adverse reactions occurred in the control group（27.06%）, which was significantly higher than that in the observation group（5 cases, 5.81%）, with statistical significance（P〈0.05）. Conclusion For the patients with ventricular arrhythmias after acute myocardial infarction, intravenous amiodarone combined with oral administration could improve clinical efficacy and reduce adverse reactions. It was worthy of clinical application and promotion.
作者
蔡小彪
Xiaobiao CAI(The People＇s Hospital of Leizhou City,Leizhou 524200,Chin)
出处
《心电图杂志（电子版）》
2018年第2期141-143,共3页
Journal of Electrocardiogram（Electronic Edition）
关键词
胺碘酮
急性心肌梗死
室性心律失常
临床效果
Amiodarone
Acute myocardial infarction
Ventricular arrhythmia
Clinical effect
